Latest Articles

Publication Date
Prevalence of Pelvic floor tension myalgia and Pelvic floor myalgia in females presenting with symptoms suggestive of endometriosis.

To estimate prevalence of pelvic floor tension myalgia and pelvic floor myalgia among individuals with endometriosis. The secondary outcome is to determine specific symptoms suggestive of pelvic floor tension myalgia/pelvic …

Published: July 31, 2026, midnight
Activin A is a functional component of the anti-endometriotic drug Endoferin.

Endometriosis is a prevalent gynecological condition affecting up to 25-40% of women with infertility. Endoferin, a protein complex derived from the bovine ovarian follicles, has demonstrated high efficacy in clinical …

Published: July 31, 2026, midnight
Lotus Endometriosis Institute Releases Guide On Missed Diagnosis Amid Care Gaps - usatoday.com

Lotus Endometriosis Institute Releases Guide On Missed Diagnosis Amid Care Gaps usatoday.com

Published: July 30, 2026, 11:49 p.m.
Lotus Endometriosis Institute Releases Guide On Missed Diagnosis Amid Care Gaps - USA Today

Lotus Endometriosis Institute Releases Guide On Missed Diagnosis Amid Care Gaps USA Today

Published: July 30, 2026, 11:49 p.m.
Following backlash, this lifesaving endometriosis and breast cancer drug will be free indefinitely - bodyandsoul.com.au

Following backlash, this lifesaving endometriosis and breast cancer drug will be free indefinitely bodyandsoul.com.au

Published: July 30, 2026, 11:45 p.m.
Karyopharm plummets as Xpovio fails in phase 3 trial for endometrial cancer - Seeking Alpha

Karyopharm plummets as Xpovio fails in phase 3 trial for endometrial cancer Seeking Alpha

Published: July 30, 2026, 11:38 p.m.
Karyopharm slumps after Xpovio misses mark in Phase III endometrial cancer study - FirstWord Pharma

Karyopharm slumps after Xpovio misses mark in Phase III endometrial cancer study FirstWord Pharma

Published: July 30, 2026, 9:59 p.m.
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint - TipRanks

Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint TipRanks

Published: July 30, 2026, 9:16 p.m.
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint - tipranks.com

Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint tipranks.com

Published: July 30, 2026, 9:16 p.m.
Update on alleged assault in Portland, Maine - newscentermaine.com

Update on alleged assault in Portland, Maine newscentermaine.com

Published: July 30, 2026, 9:12 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!